The European Bank for Reconstruction and Development (EBRD) has approved an equity investment of up to $75 million for the acquisition of Egyptian generic-drug maker Adwia Pharmaceuticals.
EBRD co-invests in pharmaceutical business
The European Bank for Reconstruction and Development (EBRD) has approved an equity investment of up to $75 million for the acquisition of Egyptian generic-drug maker Adwia Pharmaceuticals.